rs776681345
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 3P and 3B. PM2PP2BP4_ModerateBP6
The NM_001387283.1(SMARCA4):c.4261T>A(p.Ser1421Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000188 in 1,594,156 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 9/12 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001387283.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.4261T>A | p.Ser1421Thr | missense_variant | 30/36 | ENST00000646693.2 | NP_001374212.1 | |
SMARCA4 | NM_003072.5 | c.4171-1759T>A | intron_variant | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.4261T>A | p.Ser1421Thr | missense_variant | 30/36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000643549.1 | c.4162T>A | p.Ser1388Thr | missense_variant | 29/35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000344626.10 | c.4171-1759T>A | intron_variant | 1 | NM_003072.5 | ENSP00000343896.4 | ||||
SMARCA4 | ENST00000541122.6 | c.4072-1750T>A | intron_variant | 5 | ENSP00000445036.2 | |||||
SMARCA4 | ENST00000643296.1 | c.4072-1750T>A | intron_variant | ENSP00000496635.1 | ||||||
SMARCA4 | ENST00000644737.1 | c.4072-1750T>A | intron_variant | ENSP00000495548.1 | ||||||
SMARCA4 | ENST00000589677.5 | c.4072-1750T>A | intron_variant | 5 | ENSP00000464778.1 | |||||
SMARCA4 | ENST00000643995.1 | c.3583-1750T>A | intron_variant | ENSP00000496004.1 | ||||||
SMARCA4 | ENST00000644963.1 | c.2815-1750T>A | intron_variant | ENSP00000495599.1 | ||||||
SMARCA4 | ENST00000644065.1 | c.2797-1750T>A | intron_variant | ENSP00000493615.1 | ||||||
SMARCA4 | ENST00000642350.1 | c.2656-1750T>A | intron_variant | ENSP00000495355.1 | ||||||
SMARCA4 | ENST00000643857.1 | c.2524-1750T>A | intron_variant | ENSP00000494159.1 | ||||||
SMARCA4 | ENST00000538456.4 | c.328-1750T>A | intron_variant | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000446 AC: 1AN: 224130Hom.: 0 AF XY: 0.00000814 AC XY: 1AN XY: 122858
GnomAD4 exome AF: 0.00000139 AC: 2AN: 1441982Hom.: 0 Cov.: 28 AF XY: 0.00000139 AC XY: 1AN XY: 716954
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74326
ClinVar
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 26, 2023 | ClinVar contains an entry for this variant (Variation ID: 480614). This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. This variant is present in population databases (rs776681345, gnomAD 0.001%). This sequence change replaces serine, which is neutral and polar, with threonine, which is neutral and polar, at codon 1421 of the SMARCA4 protein (p.Ser1421Thr). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 01, 2024 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 11, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at